¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2023³â ´ëÇѺҾÈÀÇÇÐȸ Ãá°èÇмú´ëȸ (¹Ì·¡°¡ ºÒ¾ÈÇÏ´Ù: ÀÀ´äÇ϶ó 2023) : 2023-06-09

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2023³â ´ëÇѺҾÈÀÇÇÐȸ Ãá°èÇмú´ëȸ (¹Ì·¡°¡ ºÒ¾ÈÇÏ´Ù: ÀÀ´äÇ϶ó 2023) : 2023-06-09
±³À°ÀÏÀÚ : 2023-06-09
±³À°Àå¼Ò : ½ºÀ§½º±×·£µåÈ£ÅÚ

±³À°ÁÖÁ¦ : "2023³â ´ëÇѺҾÈÀÇÇÐȸ Ãá°èÇмú´ëȸ (¹Ì·¡°¡ ºÒ¾ÈÇÏ´Ù: ÀÀ´äÇ϶ó 2023)"

ÁÖÃÖ±â°ü : ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѺҾÈÀÇÇÐȸ (ÀÌ»çÀåÁ¦)

´ã´çÀÚ : ´ëÇѺҾÈÀÇÇÐȸ »ç¹«±¹
¿¬¶ôó : 031-787-7434

À̸ÞÀÏ : benzcl500@naver.com

±³À°Á¾·ù : Á¤½Å°Ç°­ÀÇÇаú

Âü¼®¿¹»óÀÎ : 300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 12 ½Ã°£ 40ºÐ

¼¼ºÎ¼ö°­·á : 60,000¿ø  

ºñ°í "»çÀüµî·Ïºñ - [ȸ¿øÀü¹®ÀÇ 4¸¸¿ø], [ºñȸ¿øÀü¹®ÀÇ 5¸¸¿ø], [±ºÀü¹®ÀÇ,°øº¸ÀÇ,Àü°øÀÇ 3¸¸¿ø]

ÇöÀåµî·Ïºñ - [ȸ¿øÀü¹®ÀÇ 5¸¸¿ø], [ºñȸ¿øÀü¹®ÀÇ 6¸¸¿ø], [±ºÀü¹®ÀÇ,°øº¸ÀÇ,Àü°øÀÇ 4¸¸¿ø], [Æò»ýȸ¿ø¸éÁ¦:»çÀü,ÇöÀå]"


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëA 09:30~09:55 Hurdles of Psychosurgery for Anxiety Disorders: Effects and Side Effects ÀåÁø±¸(¸íÁöº´¿ø)

±³À°½Ã°£ 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëA 09:55~10:20 Development of Lesioning Procedure: Experience from MRgFUS capsulotomy Á¤ÇöÈ£(¿¬¼¼ÀÇ´ë ½Å°æ¿Ü°ú)

±³À°½Ã°£ 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëA 10:20~10:45 Development of Neuromodulation: Experience from DBS for OCD and Tourette ÀÌÁ¤ÇÑ(¿¬¼¼ÀÇ´ë)

Åä·Ð 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëA 10:45~11:00 ÁúÀÇÀÀ´ä ()

±³À°½Ã°£ 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëA 11:10~12:00 ºÒ¾ÈÀ» ¸¶ÁÖÇÏ´Â Á¤½Å°Ç°­ÀÇÇаú Àǻ簡 ¾Ë¾Æ¾ß ÇÒ Á¤½Å¿ªµ¿°ú Á¤½ÅÄ¡·á ¹Ú¿ëõ(¹Ú¿ëõÁ¤½Å°Ç°­ÀÇÇаú)

±³À°½Ã°£ 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëA 12:10~12:35 Beyond Response: Aiming for Quality Remission in Depression °­ÁöÀÎ(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëA 12:35~13:00 Antidepressant Medication : What factors should be considered? ¹®Àº¼ö(ºÎ»êÀÇ´ë)

Åä·Ð 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëA 13:00~13:10 ÁúÀÇÀÀ´ä ()

±³À°½Ã°£ 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëA 13:20~13:45 Chat GPT°¡ ¾ð¾î¸¦ ÀÌÇØÇÏ°í ¸¸µé¾î³»´Â ¹æ¹ý ÀüÅÂÁØ(¼­¿ï¾Æ»êº´¿ø ºòµ¥ÀÌÅÍ¿¬±¸¼¾ÅÍ)

±³À°½Ã°£ 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëA 13:45~14:10 ÀÇ·áºÐ¾ß¿¡¼­ ´ëÈ­Çü ÀΰøÁö´ÉÀÇ È°¿ë: ÇöÀç¿Í ¹Ì·¡ Á¤±Ôȯ(¼º±Õ°ü´ë »ï¼ºÀ¶ÇÕÀÇ°úÇпø)

±³À°½Ã°£ 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëA 14:10~14:35 Á¤½Å°Ç°­ÀÇÇаú¿¡¼­ ´ëÈ­Çü ÀΰøÁö´ÉÀº ¾î¶»°Ô »ç¿ëµÉ ¼ö ÀÖÀ»±î? ¿ÀÁöÈÆ(°¡Å縯ÀÇ´ë)

Åä·Ð 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëA 14:35~14:50 ÁúÀÇÀÀ´ä ()

±³À°½Ã°£ 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëA 15:00~15:20 Virtual Care for Mood & Anxiety Disorder Á¤¿µÀº(Á¦ÁÖÀÇ´ë)

±³À°½Ã°£ 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëA 15:20~15:40 Overseas Models ÀÌÀçÇå(ij³ª´Ù ¿þ½ºÅϽ¶¸¯ÀÇ´ë)

±³À°½Ã°£ 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëA 15:40~16:00 Strengths & Weakness of Current Virtual Care ¹Ú¼±Ã¶(ÇѾçÀÇ´ë)

±³À°½Ã°£ 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëA 16:00~16:20 Legal and Technological Issues of Current Virtual Care Á¤Çö°­(°í·ÁÀÇ´ë)

Åä·Ð 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëA 16:20~16:30 ÁúÀÇÀÀ´ä ()

±³À°½Ã°£ 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëC 09:30~09:55 ¹üºÒ¾ÈÀå¾Ö Áø´Ü ¹× Ä¡·á¿Í °ü·ÃµÈ Àνĵµ Á¶»ç °á°ú ±è¹Î°æ(Â÷ÀÇ°úÇдë)

±³À°½Ã°£ 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëC 09:55~10:20 ÀÓ»ó¿¡¼­ ¹üºÒ¾ÈÀå¾Ö Áø´ÜÀ» °¡·Á³»±â À§ÇÑ Á¢±Ù À±¼®È£(¿µ³²ÀÇ´ë)

±³À°½Ã°£ 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëC 10:20~10:45 ´Ù¸¥ Á¤½ÅÀå¾Ö Ä¡·á¿Í ±¸º°µÇ´Â ¹üºÒ¾ÈÀå¾Ö Ä¡·á¿¡ ´ëÇÑ Á¢±Ù ¾È¸íÈñ(¼­¿ï¾Æ»êº´¿ø)

Åä·Ð 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëC 10:45~11:00 ÁúÀÇÀÀ´ä ()

±³À°½Ã°£ 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëC 11:10~12:00 ºÒ¾ÈÀ» ¸¶ÁÖÇÏ´Â Á¤½Å°Ç°­ÀÇÇаú Àǻ簡 ¾Ë¾Æ¾ß ÇÒ Á¤½Å¿ªµ¿°ú Á¤½ÅÄ¡·á ¹Ú¿ëõ(¹Ú¿ëõÁ¤½Å°Ç°­ÀÇÇаú)

±³À°½Ã°£ 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëC 12:10~12:35 Unique Efficacy and Safety of Vortioxetine in Patients with MDD ±èÁö¼±(¼øõÇâÀÇ´ë)

±³À°½Ã°£ 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëC 12:35~13:00 Effectiveness of Vortioxetine in Patients with MDD Comorbid with GAD ¹é¸íÀç(°æÈñÀÇ´ë)

Åä·Ð 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëC 13:00~13:10 ÁúÀÇÀÀ´ä ()

±³À°½Ã°£ 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëC 13:20~13:45 µðÁöÅÐ ¹Ìµð¾î°¡ ºÒ¾È¿¡ ¹ÌÄ¡´Â ¿µÇâ ÀÌÇö¾Æ(¼øõÇâÀÇ´ë)

±³À°½Ã°£ 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëC 13:45~14:10 ¿Ü·Î¿ò, »çȸÀû °í¸³°ú ¿ì¿ï, ºÒ¾È°úÀÇ °ü°è ¾ÈÁöÇö(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëC 14:10~14:35 »ó½Ç, ¾Öµµ¿Í ºÒ¾È ±è¿ø(ÀÎÁ¦ÀÇ´ë)

Åä·Ð 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëC 14:35~14:50 ÁúÀÇÀÀ´ä ()

±³À°½Ã°£ 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëC 15:00~15:25 Á¤½ÅÀÇÇÐ ºÐ¾ß ¼­ÀûÀÇ ÃֽŠÃâÆÇ µ¿Çâ ÀåÀº¼ö(ÆíÁý¹®È­½ÇÇè½Ç)

±³À°½Ã°£ 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëC 15:25~15:50 Á¤½Å°Ç°­ÀÇÇаú ÀÇ»ç·Î¼­ ´ëÁß ¼­Àû ÁýÇÊÀÇ ÀÇ¹Ì ÀüÈ«Áø(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëC 15:50~16:15 YouTube, ¹æ¼Û ¹× ´ëÁß °­¿¬À» ÅëÇØ ´ëÁß°ú ¼ÒÅëÇϱ⠱èÁö¿ë(¿¬¼¼À£Á¤½Å°Ç°­ÀÇÇаú)

Åä·Ð 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëC 16:15~16:30 ÁúÀÇÀÀ´ä ()

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2023³â ´ëÇѺҾÈÀÇÇÐȸ Ãá°èÇмú´ëȸ (¹Ì·¡°¡ ºÒ¾ÈÇÏ´Ù: ÀÀ´äÇ϶ó 2023) : 2023-06-09""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) ´ëÇѹæ»ç¼±Á¾¾çÇÐȸ KROG ½ÉÆ÷Áö¿ò – °£¾Ï/Ãé´ãµµ¾ÏºÐ°ú : 2023-06-09
´ÙÀ½±Û ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ Á¦23Â÷ Çѳ²Çмú´ëȸ : 2023-06-09
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20649 ´ëÀü °ø°ø±â°ü ÀçÁ÷ÀÇ»ç Ãá°è Çмú´ëȸ (1ÀÏÂ÷) : 2024-05-23 0 5 2024-05-10
20648 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦1Â÷¿¬¼ö±³À°(ºóÇ÷ ¹× ÃâÇ÷ Áúȯ, ÀÏÂ÷ ÀÇ·á±â°ü¿¡¼­ÀÇ °ü¸®) : 2024-05-23 0 10 2024-05-10
20647 ´ëÀü ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ ´ëÀüÃæûÁöȸ - Á¦2Â÷ ¿ù·ÊÁý´ãȸ : 2024-05-23 0 13 2024-05-10
20646 Á¦ÁÖ ´ëÇÑÇǺΰúÇÐȸ Á¦ÁÖÁöºÎȸ 2024³â Á¦1Â÷ Áý´ãȸ : 2024-05-22 0 7 2024-05-10
20645 ´ë±¸ ´ëÇѾȰúÇÐȸ ´ë±¸°æºÏÁöȸ ¿¬¼ö±³À°-¹é³»Àå ¹× Àü¾ÈºÎ ÃֽŠÁö°ß : 2024-05-21 0 7 2024-05-10
20644 ¼­¿ï ¾çõ±¸ÀÇ»çȸ Ãá°è¿¬¼ö±³À°(Á¦2Çü ´ç´¢º´°ú ¸¸¼º ½ÅÀ庴, ÀÎÁöÀå¾Ö, ¸ÞŸ¹ö½º¿Í ÀÇ·á Çõ¸í) : 2024-05-21 0 11 2024-05-10
20643 ÃæºÏ 2024 Á¦Ãµ½ÃÀÇ»çȸ Ãá°è ¿¬¼ö°­Á : 2024-05-21 0 5 2024-05-10
20642 ºÎ»ê Á¦28Â÷ ¾Æ½Ã¾Æ-¿À¼¼¾Æ´Ï¾Æ »êºÎÀΰú¿¬¸Í Çмú´ëȸ (AOFOG 2024) (4ÀÏÂ÷) : 2024-05-20 0 11 2024-05-10
20641 ¼­¿ï ´ëÇÑÀÓ»ó³ëÀÎÀÇÇÐȸ 2024 Ãá°è ³ëÀÎÀÇÇÐ ¿¬¼ö°­Á : 2024-05-19 0 18 2024-05-10
20640 ¼­¿ï ´ëÇÑÀçÈ°ÀÇÇаúÀÇ»çȸ Stanley Lam ¿öÅ©¼¥ : 2024-05-19 0 29 2024-05-10
20639 ¼­¿ï Á¦40ȸ ´ëÇѳëÀÎÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-19 0 17 2024-05-10
20638 ¼­¿ï ´ëÇÑÁ¾¾ç¿Ü°úÇÐȸ 2024³âµµ ¿¬¼ö°­Á : 2024-05-18 0 12 2024-05-10
20637 ÀÎõ 2024³âµµ Á¦47Â÷ ´ëÇѺ¹ºÎ¿µ»óÀÇÇÐȸ Çмú´ëȸ(2ÀÏÂ÷) : 2024-05-18 0 7 2024-05-10
20636 Àü³² 2024 Á¦2Â÷ ´ëÇѾȰúÀÇ»çȸ ½ÉÆ÷Áö¿ò : 2024-05-18 0 1 2024-05-10
20635 ¼­¿ï ´ëÇÑÇǺκ´¸®ÇÐȸ Á¦22ȸ ÇǺκ´¸® ½ÉÆ÷Áö¿ò : 2024-05-18 0 31 2024-05-10
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷